Sutro Biopharma, Inc.STRONASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P0
Near historical low
vs 3Y Ago
-62.7x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-222.53M-16.2%
2024$-191.54M-71.6%
2023$-111.62M-3245.0%
2022$3.55M+104.3%
2021$-81.68M-20.5%
2020$-67.80M-4.3%
2019$-65.02M-612.7%
2018$12.68M+134.2%
2017$-37.07M-181.9%
2016$-13.15M-